Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

Transfusion

Volumn 42, Issue 3, 2002, Pages 349-356

  Muerhoff, A Scott ^a,b   Jiang, Lily ^a,b   Shah, Dinesh O ^a,b   Gutierrez, Robin A ^a,b   Patel, Jigisha ^a,b   Garolis, Cynthia ^a,b   Kyrk, Charles R ^a,b   Leckie, Gregor ^a,b   Frank, Andrea ^a,b   Stewart, James L ^a,b   Dawson, George J ^a,b  

^a ABBOTT LABORATORIES   (United States)

^b ABBOTT DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN; MONOCLONAL ANTIBODY; VIRUS RNA;

ARTICLE; AUTOANALYSIS; BLOOD; BLOOD DONOR; CHEMOLUMINESCENCE; DISEASE TRANSMISSION; GENETICS; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS LOAD;

ANTIBODIES, MONOCLONAL; AUTOANALYSIS; BLOOD DONORS; CHEMILUMINESCENT MEASUREMENTS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOASSAY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 19044377790     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00052.x     Document Type: Article

References (27)

1. 1 Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 ; 345: 41 ‐ 52.
2. 2 Busch MP, Korelitz JJ, Kleinman SH, et al. Declining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection: The Retrovirus Epidemiol Donor Study. Transfusion 1995 ; 35: 903 ‐ 10.
3. 3 Stramer S, Porter R, Brodsky J. Sensitivity of HIV and HCV RNA detection by pooled genome amplification testing (GAT) (abstract). Transfusion 1998 ; 38 (Suppl): 70S.
4. 4 Busch MP, Kleinman SH, Jackson B, et al. Committee report: nucleic acid amplification testing of blood donors for transfusion‐transmitted infectious diseases: report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000 ; 40: 143 ‐ 59.
5. 5 Roth W, Weber M, Seifried E. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV‐1 in a blood‐bank setting. Lancet 1999 ; 353: 359 ‐ 63.
6. 6 Stramer SL, Caglioti S, Strong DM. NAT of the united states and canadian blood supply. Transfusion 2000 ; 40: 1165 ‐ 8.
7. 7 Aoyagi K, Ohue C, Iida K, et al. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999 ; 37: 1802 ‐ 8.
8. 8 Courouce AM, Le Marrec N, Bouchardeau F, et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000 ; 40: 1198 ‐ 202.
9. 9 Dawson G, Jiang L, Muerhoff A, et al. Detection of exposure to hepatitis C virus utilizing a prototype HCV antigen test (abstract). Transfusion 2000 ; 40 (Suppl): 83S.
10. 11 Kobayashi M, Chayama K, Arase Y, et al. Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha. J Gastroenterol 1999 ; 34: 94 ‐ 9.
11. 12 Tanaka E, Ohue C, Aoyagi K, et al. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Hepatology 2000 ; 32: 388 ‐ 93.
12. 13 Komatsu F, Takasaki K. Determination of serum hepatitis C virus (HCV) core protein using a novel approach for quantitative evaluation of HCV viraemia in anti‐HCV‐positive patients. Liver 1999 ; 19: 375 ‐ 80.
13. 14 Orito E, Mizokami M, Tanaka T, et al. Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes. Gut 1996 ; 39: 876 ‐ 80.
14. 15 Tokita H, Kaufmann GR, Matsubayashi M, et al. Hepatitis C virus core mutations reduce the sensitivity of a fluorescence enzyme immunoassay. J Clin Microbiol 2000 ; 38: 3450 ‐ 2.
15. 16 Dickson RC, Mizokami M, Orito E, et al. Quantification of serum HCV core antigen by a fluorescent enzyme immunoassay in liver transplant recipients with recurrent hepatitis C: clinical and virologic implications. Transplantation 1999 ; 68: 1512 ‐ 6.
16. 17 Iijima A, Tanaka E, Kobayashi M, et al. Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum. J Gastroenterol Hepatol 2000 ; 15: 311 ‐ 9. DOI: 10.1046/j.1440-1746.2000.02127.x
17. 18 Shiratori Y, Kato N, Yokosuka O, et al. Quantitative assays for hepatitis C virus in serum as predictors of the long‐term response to interferon. J Hepatol 1997 ; 27: 437 ‐ 44.
18. 19 Tanaka T, Lau JY, Mizokami M, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia. J Hepatol 1995 ; 23: 742 ‐ 5.
19. 20 Khalil OS, Zurek TF, Tryba J, et al. Abbott PRISM: a multichannel heterogeneous chemiluminescence immunoassay analyzer. Clin Chem 1991 ; 37: 1540 ‐ 7.
20. 21 Shah DO, Stewart J. Automated panel analyzers PRISM. In: David Wild, ed. The immunoassay handbook. New York: Nature Publishing Group, 2001: 297 ‐ 303.
21. 22 Hottentrager B, Lennartz L, Michel G, et al. Evaluation of a new assay for the quantitative measurement of HCV RNA levels (abstract). Hepatology 2001 ; 34: 128, A1327.
22. 23 Pawlotsky J‐M, Jilg W, Zanetti AR, et al. Multi‐center evaluation of the LCx HCV RNA quantitative assay (abstract). Hepatology 2001 ; 34: 128, A1328.
23. 24 Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA 1992 ; 89: 187 ‐ 91.
24. 25 Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS‐5 region. J Gen Virol 1993 ; 74: 2391 ‐ 9.
25. 26 Felsenstein J. PHYLIP inference package, version 3.5c. Department of Genetics, University of Washington, Seattle, WA: Felsenstein, 1993.
26. 27 Muerhoff AS, Smith DB, Leary TP, et al. Identification of GB virus C variants by phylogenetic analysis of 5′‐ untranslated and coding region sequences. J Virol 1997 ; 71: 6501 ‐ 8 ; erratum in J Virol 1997;71:8952.
27. 28 Roth WK, Buhr S, Drosten C, et al. NAT and viral safety in blood transfusion. Vox Sang 2000 ; 78 (Suppl 2): 257 ‐ 9.